San Francisco, CA Genedata, a leading provider of advanced software solutions for biopharma R&D, today announced that Seattle-based Aptevo Therapeutics, a clinical-stage biotechnology company, has adopted Genedata as their preferred bioinformatics solution provider. Aptevo will use the Genedata Biologics® platform to facilitate expansion of their pipeline of novel bispecific antibody candidates focused on immuno-oncology, autoimmune disease and inflammation. […]
LANSING, Mich. — Neogen’s revolutionary Listeria Right Now™ environmental pathogen detection system has officially achieved AOAC approval, license number #081802. The approval adds another level of assurance to the food safety community, as the product has now been validated by one of the industry’s leading third-party accreditation groups. “It’s extremely gratifying to receive this approval,” said John Adent, […]
New acquisition rounds out Diagenode’s epigenomics profiling services platform DENVILLE, N.J. AND LIEGE, BELGIUM Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider based in Gent, Belgium. NXT-Dx provides a broad variety of start-to-finish epigenetics services including a number of targeted DNA methylation assays using pyrosequencing or Next-Generation Sequencing and Illumina’s Infinium […]
Acquisition of US-based NuGEN expands Tecan’s dedicated solutions offering into new market segment of next-generation sequencing (NGS) reagents and increases overall recurring revenues NuGEN provides innovative NGS kits and genomic sample prep reagents for the fastest growing field within the genomics area NuGEN to become part of Tecan’s Life Sciences Business, leveraging Tecan’s global presence and […]
Merck today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases. DARMSTADT, GERMANY Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research Expands company’s foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients […]
San Diego, CA — Synthetic Genomics, Inc. (SGI), a leader in designing and programming biology for function, today announced J. Craig Venter, Ph.D., has retired from his longtime position as Chairman of the company’s Board of Directors to focus on his work at the J. Craig Venter Institute (JCVI). Dr. Venter will remain a Scientific […]
Ft. Collins, CO (Fort Collins, CO) – KromaTiD, Inc. announced today that it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the National Human Genome Research Institute. The SBIR program enables scientific excellence and technological innovation by incentivizing small businesses to engage in commercial research and development. This award will fund the […]
Wageningen, Netherlands; San Carlos, CA, USA Today NuGEN Technologies, Inc. and Keygene N.V. announced an agreement to settle a declaratory judgment lawsuit brought by NuGEN Technologies concerning KeyGene’s U.S. Patent Nos. 9,702,004, 9,745,627 and 9,896,721. Under the terms of the settlement, the lawsuit and counterclaims have been dismissed. Financial terms and other specifics of the settlement were […]
BEIJING & CAMBRIDGE, Mass.–EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery, today announced the successful completion of approximately $15 Million in a Series pre-B financing. The financing is led by new investor Lilly Asia Ventures (LAV). New investor Huagai […]
Genomic Vision grants European Equity Partner (EEP) a license to its proprietary technology. During the evaluation period, the parties will confirm interest of molecular combing as a genome integrity assay as a quality control tool in biomanufacturing of proteins This strategic collaboration is aimed at building a Bioanalytical Services Company offering specific leading analytical services […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
